France - Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale
Since 2014, France Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale fell by 2.6% year on year. At €642,378,032.96 in 2019, the country was ranked number 5 comparing other countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. France is overtaken by Germany, which was ranked number 4 at €718,679,434.78 and is followed by Spain at €176,754,726.66. Denmark topped the ranking with €3,801,340,964.3 in 2019, a decrease of 2.9% compared to 2018. Italy witnessed the best average annual growth at +51.7% per year, while Netherlands was the worst growing country at -13.4% per year.
Loading...
Date | Euros |
---|---|
2019 | 642,378,032.96 |
2018 | 625,470,227.00 |
2017 | 861,518,926.00 |
2016 | 819,403,528.00 |
2015 | 942,169,940.00 |
How does France rank in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?
# | 16 Countries | Euros | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Denmark
|
3,801,340,964.30 | 2019 | -2.9 % | +26.5 % | View data | |
2 |
#2
Belgium
|
1,624,727,500.00 | 2018 | +46.2 % | NA | View data | |
4 |
#4
Germany
|
718,679,434.78 | 2019 | -1.4 % | -4.9 % | View data | |
5 |
#5
France
|
642,378,032.96 | 2019 | +2.7 % | -2.6 % | View data | |
6 |
#6
Spain
|
176,754,726.66 | 2019 | +0.2 % | +7.5 % | View data |